Projects per year
Abstract
Mupirocin, a clinically important antibiotic produced via a trans-AT Type I polyketide synthase (PKS) in Pseudomonas fluorescens, consists of a mixture of mainly pseudomonic acids A, B, and C. Detailed metabolic profiling of mutant strains produced by systematic inactivation of PKS and tailoring genes, along with re-feeding of isolated metabolites to mutant stains, has allowed the isolation of a large number of novel metabolites, identification of the 10,11-epoxidase, and full characterization of the mupirocin biosynthetic pathway, which proceeds via major (10,11-epoxide) and minor (10,11-alkene) parallel pathways.
Original language | English |
---|---|
Pages (from-to) | 5501-5507 |
Number of pages | 7 |
Journal | Journal of the American Chemical Society |
Volume | 136 |
Issue number | 14 |
Early online date | 27 Mar 2014 |
DOIs | |
Publication status | Published - 9 Apr 2014 |
ASJC Scopus subject areas
- General Chemistry
- Catalysis
- Biochemistry
- Colloid and Surface Chemistry
- General Medicine
Fingerprint
Dive into the research topics of 'Biosynthesis of mupirocin by pseudomonas fluorescens NCIMB 10586 involves parallel pathways'. Together they form a unique fingerprint.Projects
- 3 Finished
-
Novel hybrid anti-MRSA antibiotics from manipulation of the mupirocin and thiomarinol biosynthetic pathways
Thomas, C. (Principal Investigator) & Winn, P. (Co-Investigator)
Biotechnology & Biological Sciences Research Council
1/10/11 → 31/12/14
Project: Research Councils
-
Biosynthesis of polyketide antibiotic mupirocin by Pseudomonas fluorescens
Thomas, C. (Principal Investigator)
Biotechnology & Biological Sciences Research Council
1/06/07 → 30/01/11
Project: Research Councils
-
Biosynthesis of the Polyketide Antibiotic Mupirocin by Pseudomonas Fluorescens
Thomas, C. (Principal Investigator) & Hothersall, J. (Co-Investigator)
Biotechnology & Biological Sciences Research Council
14/05/04 → 13/05/07
Project: Research Councils